Carver Kyle bought EVMN
November 7, 2025 · Form 4 insider transaction
Carver Kyle bought 3,175 shares of Evommune, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,175
Price
N/A
Total value
N/A
InsiderCarver Kyle
RoleOfficer
CompanyEvommune, Inc. (EVMN)
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateNovember 7, 2025
Filing dateNovember 12, 2025
Shares owned after75,800
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-7.8721 basis and had no expiration date.